Bioton (LTS:0DTR) Inventories, Raw Materials & Components: zł37.4 Mil (As of Mar. 2026)


LTS:0DTR Bioton SA LTS:0DTR
67 GF Score
Price zł3.43
GF Value zł4.09
! 3 Warning Signs
View Full Analysis

What is Bioton Inventories, Raw Materials & Components?

Bioton LTS:0DTR 67 Inventories, Raw Materials & Components is zł37.4 Mil as of Mar. 2026. GuruFocus rates LTS:0DTR with a GF Score™ of 67/100 and a GF Value™ of zł4.09. The stock has 3 warning signs investors should review.

Bioton's inventories, raw materials & components for the quarter that ended in Mar. 2026 was zł37.4 Mil.

Bioton's quarterly raw materials declined from Sep. 2025 (zł34.2 Mil) to Dec. 2025 (zł33.5 Mil) but then increased from Dec. 2025 (zł33.5 Mil) to Mar. 2026 (zł37.4 Mil).

Bioton's annual raw materials declined from Dec. 2023 (zł42.9 Mil) to Dec. 2024 (zł34.7 Mil) and declined from Dec. 2024 (zł34.7 Mil) to Dec. 2025 (zł33.5 Mil).

Bioton Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Bioton's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioton Inventories, Raw Materials & Components Chart

Bioton Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.09 41.25 42.87 34.75 33.49

Bioton Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 34.23 33.49 37.39
LTS:0DTR
67GF Score
Bioton SA LTS:0DTR
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioton Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of zł37.4 Mil mean?
Bioton (LTS:0DTR) has a Inventories, Raw Materials & Components of zł37.4 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Bioton and its competitors.
Is Bioton's Inventories, Raw Materials & Components too high?
Bioton's current Inventories, Raw Materials & Components is zł37.4 Mil. Overall, Bioton has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Bioton's Inventories, Raw Materials & Components compare to VRTX and REGN?
Bioton's Inventories, Raw Materials & Components of zł37.4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Bioton and its competitors. Bioton's current Inventories, Raw Materials & Components is zł37.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioton stock overvalued right now?
Bioton (LTS:0DTR) has a current Inventories, Raw Materials & Components of zł37.4 Mil. The stock's GF Value™ is zł4.09, compared to a current price of zł3.43 — trading 16.2% below its estimated fair value. The current Inventories, Raw Materials & Components is zł37.4 Mil. Bioton's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Bioton (LTS:0DTR), the current Inventories, Raw Materials & Components is zł37.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioton (LTS:0DTR) Overvalued in 2026?

Based on GuruFocus' analysis, Bioton stock appears to be undervalued. The current stock price of zł3.43 is trading 16.2% below its estimated GF Value™ of zł4.09.

Key valuation signals for LTS:0DTR:

  • Inventories, Raw Materials & Components: zł37.4 Mil
  • GF Value™: zł4.09 vs. price of zł3.43 (16.2% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the LTS:0DTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioton Business Description

Other Exchanges BIO:Poland7U5:Germany
Address Ul. Starościńska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
67GF Score

Get the complete analysis for LTS:0DTR

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.43
Price
zł4.09
GF Value